Oracle Announces Non-Binding Agreement With AstraZeneca To Explore AI And Real-World Data For Clinical Trial Patient Identification, Evidence Generation And Care Insights

Oracle has entered a non-binding agreement with AstraZeneca to explore the use of AI and real-world data for clinical trial patient identification and evidence generation. This collaboration aims to leverage AstraZeneca's scientific expertise alongside Oracle's cloud and AI capabilities to enhance clinical research and improve patient care workflows.